ESR1 and metabolic disease: Indeed, the fact that striking sex differences exist in adipose tissue health and susceptibility to metabolic disease, such that females are largely protected from adipose tissue dysfunction and its related diseases [58], gives us reason to explore E2 and E2 receptor (ER) signaling as a potential mechanism for improving adipocyte metabolism.